Schulman Bhattacharya, LLC, along with Boston-based co-counsel Shapiro Haber & Urmy LLP, just secured a significant legal victory for consumers nationwide in Starr, et al. v. VSL Pharmaceuticals, Inc., et al. (Civil Action No. 19-cv-02173-LKG). In the Starr case, Schulman Bhattacharya represents the plaintiffs in a class action litigation against the licensor and distributors of the probiotic VSL#3®. On January 28, 2025, the U.S. District Court for the District of Maryland issued a 33-page opinion granting plaintiffs’ motion for... read more →

Schulman Bhattacharya secured an important victory for its clients, two commercial lending companies, in the New York State Supreme Court, which granted the Firm’s motion for summary judgment and awarded the Firm’s clients a nearly $10.5 million judgment. The Firm’s clients had issued a multimillion-dollar loan to the defendants who had defaulted on their payment obligations. The Firm proceeded to file a motion for summary judgment in lieu of a complaint pursuant to New York law, seeking an immediate... read more →

Schulman Bhattacharya secured an important victory for its clients, two leading biotechnology entrepreneurs, in the United States District Court for the District of Massachusetts, which granted the Firm’s motion to dismiss the plaintiffs’ complaint in its entirety.  The seven-count complaint had alleged federal and state securities fraud and related claims in connection with investments the plaintiffs made through a series of convertible promissory notes.  The Firm’s clients vehemently denied any wrongdoing and were poised to vigorously contest the... read more →

Schulman Bhattacharya is proud to announce the hiring of Renan Varghese, an accomplished litigator focused on commercial disputes, including employment litigation, class action litigation, wage and hour litigation, appellate litigation, sexual assault cases and police brutality cases. Mr. Varghese previously worked for one of the premier employment litigation firms in New York City, where he represented high profile clients across many industries, including sports, entertainment, and politics. Jeremy Schulman, Managing Member of Schulman Bhattacharya, stated: “We are very pleased... read more →

CNBC had published a lengthy piece about the Firm’s client, Marjorie Bloom, a retired federal government employee who lost her life savings to a common elder fraud scheme. The Firm is proud to have represented Ms. Bloom in the ensuing federal court litigation. The CNBC article, which has attracted nearly 1 million views, may be found by clicking here and here. Read the full story here View the PDF here

On March 3, 2023, the United States District Court for the District of Columbia issued a groundbreaking decision allowing Schulman Bhattacharya’s client, Marjorie Bloom, to proceed with her lawsuit against PNC Bank, N.A., in a ruling that has significant implications for the banking industry. Schulman Bhattacharya defeated PNC’s motion to dismiss, with the Court holding that PNC owed Ms. Bloom a contractual duty of care to investigate and intervene when faced with clear evidence of elder financial exploitation.... read more →

Schulman Bhattacharya secured another major victory last week for ExeGi Pharma, LLC and its flagship probiotic product, Visbiome. In ExeGi’s lawsuit against competitor Brookfield Pharmaceuticals, LLC, the United States District Court for the Eastern District of Wisconsin granted in part ExeGi’s motion for partial summary judgment, finding in ExeGi’s favor as to liability on its Lanham Act false advertising and common law unfair competition claims.  While ExeGi will go to trial to determine its damages, Judge J.P. Stadtmueller... read more →

On September 23, 2022, Schulman Bhattacharya secured another victory for its client, Claudio De Simone, the inventor of the acclaimed probiotic product known as the De Simone Formulation.  The De Simone Formulation was formerly sold under the trademark VSL#3® and is now sold under the trademark Visbiome®.  In the recent court action, Professor De Simone prevailed again against VSL Pharmaceuticals, Inc., the owner of the VSL#3® trademark, and its licensees, Alfasigma USA, Inc., and Leadiant Biosciences, Inc. On... read more →

The United States Court of Appeals for the Fourth Circuit issued a unanimous, published decision today affirming yet another victory secured by Schulman Bhattacharya for its clients Claudio De Simone and ExeGi Pharma, LLC against Alfasigma USA, Inc. and VSL Pharmaceuticals, Inc. On July 30, 2020, Judge Theodore D. Chuang for the United States District Court of Maryland granted the Firm’s motion and held Alfasigma and VSL in civil contempt and sanctioned them for violating the Court’s permanent... read more →

On May 20, 2021, Schulman Bhattacharya filed a Complaint in the United States District Court for the Northern District of Georgia on behalf of ExeGi Pharma, LLC against Roberto Pacifici, a Professor of Medicine at the Emory University School of Medicine.  The suit asserted, among other things, a claim against Dr. Pacifici for Contributory False Advertising in violation of the Lanham Act arising out of a false advertising scheme facilitated by Dr. Pacifici that has damaged and continues... read more →